Halozyme Therapeutics | HALO - EPS ربحية السهم


Fiscal التقويم فعلي إجماع السابق تاريخ
FY2026Q1 Mar/2026 1.76 1.11 May/12
FY2025Q4 Dec/2025 -0.24 1.9 1.26 Feb/17
FY2025Q3 Sep/2025 1.72 1.59 1.27 Nov/03
FY2025Q2 Jun/2025 1.54 1.21 0.91 Aug/05
FY2025Q1 Mar/2025 1.11 0.96 0.79 May/06




Eps تغيير تاريخ
Acadia Pharmaceuticals USD 1.6 1.18 2025-12
Agios Pharmaceuticals USD -1.69 0.17 2026-03
Alnylam Pharmaceuticals USD 1.25 1.65 2025-12
Amarin USD 0.14 0.06 2025-12
Amgen USD 5.29 0.35 2025-12
Baxter International USD 0.44 0.25 2025-12
Cara Therapeutics USD -0.59 4.45 2025-09
Cytokinetics USD -1.5 1.05 2025-12
DBV Technologies USD -0.24 1.31 2025-09
Eli Lilly USD 7.54 0.52 2025-12
Esperion Therapeutics USD 0.26 0.42 2025-12
Halozyme Therapeutics USD -0.24 1.96 2025-12
Intrexon USD -0.1 0.03 2024-06
Ionis Pharmaceuticals USD -0.56 0.85 2026-03
MannKind USD 0.01 0.06 2025-12
Minerva Neurosciences USD -0.56 3.53 2024-12
Nektar Therapeutics USD -1.35 1.17 2025-12
Pfizer USD 0.66 0.21 2025-12
Rigel Pharmaceuticals USD 0.7 0.76 2024-09
United Therapeutics USD 7.7 0.54 2025-12
Vanda Pharmaceuticals USD -0.09 0 2024-12